MedTrace Logo

PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer

NCT04883450 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2024-01-16

No results posted yet for this study

Summary

Conduct a prospective study to assess the accuracy of a pancreatic cancer risk prediction model.

Conditions

Interventions

DIAGNOSTIC_TEST

Magnetic resonance imaging (MRI)

All enrolled participants will undergo magnetic resonance imaging (MRI) at their Baseline and 18-Month follow-up visit

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Bechien U Wu, MD, MPH · Kaiser Permanente

Eligibility

Min Age
50 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2024-12-31
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04883450 on ClinicalTrials.gov